| CAT No: | CL-PUBN-03 |
| CAS No: | NA |
| Mol.F: | C31H35NO13 |
| Mol.Wt.: | 629.6 |
| Chemical Name: | (2S,4S)-4-(((2R,4S,5S,6S)-4-amino-6-methyl-5-(((R)-tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-2-carboperoxoic acid |
| Inventory Status: | Custom synthesis |
This impurity is related to Pirarubicin Ester Impurity is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Pirarubicin Ester Impurity is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(2S,4S)-4-(((2R,4S,5S,6S)-4-amino-6-methyl-5-(((R)-tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-2-carboperoxoic acidCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Pirarubicin Molecular Formula: C31H35NO13
Molecular Weight: 629.6
Storage: Store in a cool, dry place.
| Product Name: | Pirarubicin Ester Impurity |
| CAS No: | |
| Mol.F.: | C31H35NO13 |
| Mol.Wt.: | 629.6 |
Cat. No: CL-PUBN-01
CAS No: 72496-41-4
Mol. F: C32H37NO12
Mol. Wt: 627.6
Inv. Status: Custom Synthesis
Cat. No: CL-PUBN-02
CAS No: NA
Mol. F: C64H74N2O24
Mol. Wt: 1255.3
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: